Lepu to Use Pharma Arm To Acquire Cardiovasculars
This article was originally published in PharmAsia News
Executive Summary
The vice-chairman of Lepu Medical, Pu Zhongjie, has stated that the firm’s Lepu Pharmaceutical operation will serve as a platform for the company to acquire and in-license new cardiovascular drugs.